{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:49:51Z","timestamp":1792457391929,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/100031951","name":"Sciensano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031951","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Congenital cytomegalovirus (cCMV) is the most common congenital infection worldwide and a major cause of sensorineural hearing loss. A limited number of infants present with severe symptoms, including end-organ disease, developmental delay and neurologic sequelae. Infants with severe cCMV benefit from 6 months of valganciclovir (VGCV) therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We describe a newborn with a severe cCMV infection after primary maternal infection in the first trimester of pregnancy. Cytomegalovirus (CMV) viral load and genotype were monitored throughout infection. Prospective resistance analysis was performed by Sanger sequencing of the DNA polymerase (\n                      <jats:italic toggle=\"yes\">UL54<\/jats:italic>\n                      ) and protein kinase (PK;\n                      <jats:italic toggle=\"yes\">UL97<\/jats:italic>\n                      ) genes. Whole-genome sequencing was achieved with RNA probe-based target enrichment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Prospective resistance analysis identified 2 PK ganciclovir resistance mutations following an increase in viral load under VGCV treatment. PK-M460V and PK-C592G were found as mixed viral populations and combination foscarnet + VGCV therapy was started in response. The patient responded to treatment and viral load decreased, but did not reach undetectable levels during follow-up. A pure population of virus carrying the PK-M460V substitution was established. The patient is currently doing well with limited sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Limited data exist on the prevalence and clinical consequences of drug resistance in cCMV. The case described here depicts the surveillance of viral infection and the emergence of drug resistance, which was managed by administering combination antiviral therapy. It emphasizes the need for further research into the management of severe cCMV infections and the need for monitoring antiviral drug resistance to implement adapted treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004948","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T21:04:42Z","timestamp":1755637482000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Emergence of Antiviral Drug Resistance in Congenital Cytomegalovirus Infection During Treatment: An Updated Review of Literature and Case Report"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-3731","authenticated-orcid":false,"given":"Fien","family":"Horsten","sequence":"first","affiliation":[{"name":"Molecular, Structural and Translational Virology Research Group, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gillemot","sequence":"additional","affiliation":[{"name":"Molecular, Structural and Translational Virology Research Group, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0746-2737","authenticated-orcid":false,"given":"Sarah","family":"Dorval","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang","family":"Ho","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biology, Clinique MontL\u00e9gia, CHC, Li\u00e8ge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-5232","authenticated-orcid":false,"given":"Piet","family":"Maes","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Epidemiological Virology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-5434","authenticated-orcid":false,"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[{"name":"Molecular, Structural and Translational Virology Research Group, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-4896","authenticated-orcid":false,"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[{"name":"Molecular, Structural and Translational Virology Research Group, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection.","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2005.09.016","article-title":"Congenital cytomegalovirus (CMV) infection and hearing deficit.","volume":"35","author":"Fowler","year":"2006","journal-title":"J Clin Virol"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 4","key":"R5-20251215","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: clinical outcome.","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.3390\/jcm13195997","article-title":"Congenital cytomegalovirus severity definitions and treatment decisions around the world: a systematic scoping review of the literature.","volume":"13","author":"Boscarino","year":"2024","journal-title":"J Clin Med"},{"issue":"5 Pt 1","key":"R7-20251215","first-page":"658","article-title":"Increased risk of cytomegalovirus transmission in utero during late gestation.","volume":"93","author":"Bod\u00e9us","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcv.2009.11.009","article-title":"Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions.","volume":"47","author":"Bod\u00e9us","year":"2010","journal-title":"J Clin Virol"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcv.2010.12.012","article-title":"Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience.","volume":"50","author":"Revello","year":"2011","journal-title":"J Clin Virol"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.","volume":"52","author":"Enders","year":"2011","journal-title":"J Clin Virol"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management.","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI).","volume":"40","author":"Leruez-Ville","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease.","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"105083","DOI":"10.1016\/j.antiviral.2021.105083","article-title":"Clinical outcome and the role of antivirals in congenital cytomegalovirus infection.","volume":"191","author":"Ross","year":"2021","journal-title":"Antiviral Res"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.mph.0000135283.77668.6a","article-title":"Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.","volume":"26","author":"Blackman","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/clinpract14060191","article-title":"Progress and challenges in the management of congenital cytomegalovirus infection.","volume":"14","author":"Szulc","year":"2024","journal-title":"Clin Pract"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1128\/AAC.00802-10","article-title":"Improved detection of mutated human cytomegalovirus UL97 by pyrosequencing.","volume":"54","author":"Schindele","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-010-0181-y","article-title":"Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection.","volume":"200","author":"Kampmann","year":"2011","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"105792","DOI":"10.1016\/j.antiviral.2023.105792","article-title":"Ganciclovir and maribavir cross-resistance revisited: relative drug susceptibilities of canonical cytomegalovirus mutants.","volume":"222","author":"Chou","year":"2024","journal-title":"Antiviral Res"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-0934(97)00093-1","article-title":"Value of a ligase chain reaction assay for detection of ganciclovir resistance-related mutation 594 in UL97 gene of human cytomegalovirus.","volume":"67","author":"Bourgeois","year":"1997","journal-title":"J Virol Methods"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcv.2012.01.006","article-title":"Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients.","volume":"54","author":"Benzi","year":"2012","journal-title":"J Clin Virol"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcv.2012.01.020","article-title":"Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection.","volume":"54","author":"Campanini","year":"2012","journal-title":"J Clin Virol"},{"key":"R24-20251215","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/516446","article-title":"Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.","volume":"175","author":"Erice","year":"1997","journal-title":"J Infect Dis"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jcv.2013.04.004","article-title":"Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.","volume":"57","author":"Choi","year":"2013","journal-title":"J Clin Virol"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12887-017-0933-6","article-title":"Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.","volume":"17","author":"Morillo-Gutierrez","year":"2017","journal-title":"BMC Pediatr"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijid.2020.06.087","article-title":"Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection.","volume":"98","author":"Garofoli","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12879-022-07537-6","article-title":"Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study.","volume":"22","author":"Torii","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/jiaa462","article-title":"Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection.","volume":"226","author":"Chou","year":"2022","journal-title":"J Infect Dis"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.00186-10","article-title":"Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.","volume":"54","author":"Chou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus.","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"105139","DOI":"10.1016\/j.antiviral.2021.105139","article-title":"Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing.","volume":"193","author":"Chou","year":"2021","journal-title":"Antiviral Res"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.antiviral.2019.06.004","article-title":"Persistent primary cytomegalovirus infection in a kidney transplant recipient: multi-drug resistant and compartmentalized infection leading to graft loss.","volume":"168","author":"Andrei","year":"2019","journal-title":"Antiviral Res"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/TP.0000000000005209","article-title":"Dynamics and evolution of donor-derived cytomegalovirus infection in 3 solid organ transplant recipients with the same multiorgan donor.","volume":"109","author":"Horsten","year":"2025","journal-title":"Transplantation"},{"key":"R36-20251215","doi-asserted-by":"crossref","first-page":"106016","DOI":"10.1016\/j.antiviral.2024.106016","article-title":"Comprehensive herpesviruses antiviral drug resistance mutation database (CHARMD).","volume":"231","author":"Tilloy","year":"2024","journal-title":"Antiviral Res"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"key":"R38-20251215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3851\/IMP3238","article-title":"Antiviral combination therapy for cytomegalovirus infection in high-risk infants.","volume":"23","author":"Vora","year":"2018","journal-title":"Antivir Ther"},{"key":"R39-20251215","doi-asserted-by":"crossref","first-page":"e0011024","DOI":"10.1128\/aac.00110-24","article-title":"Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.","volume":"68","author":"Schalkwijk","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-20251215","doi-asserted-by":"crossref","first-page":"veae101","DOI":"10.1093\/ve\/veae101","article-title":"Combined use of pritelivir with acyclovir or foscarnet suppresses evolution of HSV-1 drug resistance.","volume":"10","author":"Schalkwijk","year":"2024","journal-title":"Virus Evol"},{"key":"R41-20251215","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.","volume":"85","author":"Goldner","year":"2011","journal-title":"J Virol"},{"key":"R42-20251215","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/S2352-3026(23)00344-7","article-title":"Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"11","author":"Russo","year":"2024","journal-title":"Lancet Haematol"},{"key":"R43-20251215","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial.","volume":"75","author":"Avery","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R44-20251215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jpids\/piae093.071","article-title":"Maribavir use in pediatric immunocompromised hosts: a case series to talk about real-world experience.","volume":"13","author":"Doshi","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R45-20251215","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/infdis\/jiy695","article-title":"Blood viral load in symptomatic congenital cytomegalovirus infection.","volume":"219","author":"Marsico","year":"2019","journal-title":"J Infect Dis"},{"key":"R46-20251215","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R47-20251215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"R48-20251215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/uog.23685","article-title":"Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.","volume":"58","author":"Faure\u2010Bardon","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R49-20251215","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta\u2010analysis.","volume":"61","author":"D\u2019Antonio","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R50-20251215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/uog.26039","article-title":"New data on efficacy of valacyclovir in secondary prevention of maternal\u2013fetal transmission of cytomegalovirus.","volume":"61","author":"Egloff","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R51-20251215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","article-title":"The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis.","volume":"230","author":"Chatzakis","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R52-20251215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12884-024-06367-5","article-title":"Hygiene-based measures for the prevention of cytomegalovirus infection in pregnant women: a systematic review.","volume":"24","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"R53-20251215","first-page":"39","article-title":"Losing ground","volume":"1","author":"Doutre","year":"2016","journal-title":"J Early Hear Detect Interv"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:00:59Z","timestamp":1765803659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004948","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}